ENvue Medical (FEED) Return on Equity (2014 - 2026)

ENvue Medical (FEED) has 13 years of Return on Equity data on file, last reported at 0.01% in Q1 2026.

• Quarterly Return on Equity rose 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, up 1.0% from the prior year.
• Return on Equity rose to 0.01% in Q1 2026 per FEED's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Equity topped out at 0.86% in Q2 2023 and bottomed at 0.0% in Q2 2025.
• The 5-year median for Return on Equity is 0.01% (2025), against an average of 0.15%.
• The widest annual swing landed in 2023, when Return on Equity jumped 82 bps; it then plunged 85 bps in 2024.
• Tracing FEED's Return on Equity over 5 years: stood at 0.45% in 2022, then slumped by 100 bps to 0.0% in 2023, then tumbled by 184 bps to 0.0% in 2024, then surged by 679 bps to 0.01% in 2025, then grew by 4 bps to 0.01% in 2026.
• Per Business Quant, the three latest FEED Return on Equity figures stand at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025).

Peer Comparison